Biology and therapeutic potential of mesenchymal stem cell‐derived exosomes

Mesenchymal stem cells (MSC) are multipotent stromal cells with the potential to differentiate into several cell types. MSC‐based therapy has emerged as a promising strategy for various diseases. Accumulating evidence suggests that the paracrine effects of MSC are partially exerted by the secretion...

Full description

Saved in:
Bibliographic Details
Published inCancer science Vol. 111; no. 9; pp. 3100 - 3110
Main Authors Xunian, Zhou, Kalluri, Raghu
Format Journal Article
LanguageEnglish
Published Tokyo John Wiley & Sons, Inc 01.09.2020
John Wiley and Sons Inc
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Mesenchymal stem cells (MSC) are multipotent stromal cells with the potential to differentiate into several cell types. MSC‐based therapy has emerged as a promising strategy for various diseases. Accumulating evidence suggests that the paracrine effects of MSC are partially exerted by the secretion of soluble factors, in particular exosomes. MSC‐derived exosomes are involved in intercellular communication through transfer of proteins, RNA, DNA and bioactive lipids, which might constitute a novel intercellular communication mode. This review illustrates the current knowledge on the composition and biological functions as well as the therapeutic potential of MSC‐derived exosomes in cancer, with a focus on clinical translation opportunities. The biology and therapeutic potential of mesenchymal stem cell‐derived exosomes.
AbstractList Mesenchymal stem cells (MSC) are multipotent stromal cells with the potential to differentiate into several cell types. MSC-based therapy has emerged as a promising strategy for various diseases. Accumulating evidence suggests that the paracrine effects of MSC are partially exerted by the secretion of soluble factors, in particular exosomes. MSC-derived exosomes are involved in intercellular communication through transfer of proteins, RNA, DNA and bioactive lipids, which might constitute a novel intercellular communication mode. This review illustrates the current knowledge on the composition and biological functions as well as the therapeutic potential of MSC-derived exosomes in cancer, with a focus on clinical translation opportunities.Mesenchymal stem cells (MSC) are multipotent stromal cells with the potential to differentiate into several cell types. MSC-based therapy has emerged as a promising strategy for various diseases. Accumulating evidence suggests that the paracrine effects of MSC are partially exerted by the secretion of soluble factors, in particular exosomes. MSC-derived exosomes are involved in intercellular communication through transfer of proteins, RNA, DNA and bioactive lipids, which might constitute a novel intercellular communication mode. This review illustrates the current knowledge on the composition and biological functions as well as the therapeutic potential of MSC-derived exosomes in cancer, with a focus on clinical translation opportunities.
Mesenchymal stem cells (MSC) are multipotent stromal cells with the potential to differentiate into several cell types. MSC‐based therapy has emerged as a promising strategy for various diseases. Accumulating evidence suggests that the paracrine effects of MSC are partially exerted by the secretion of soluble factors, in particular exosomes. MSC‐derived exosomes are involved in intercellular communication through transfer of proteins, RNA, DNA and bioactive lipids, which might constitute a novel intercellular communication mode. This review illustrates the current knowledge on the composition and biological functions as well as the therapeutic potential of MSC‐derived exosomes in cancer, with a focus on clinical translation opportunities.
Mesenchymal stem cells (MSC) are multipotent stromal cells with the potential to differentiate into several cell types. MSC‐based therapy has emerged as a promising strategy for various diseases. Accumulating evidence suggests that the paracrine effects of MSC are partially exerted by the secretion of soluble factors, in particular exosomes. MSC‐derived exosomes are involved in intercellular communication through transfer of proteins, RNA, DNA and bioactive lipids, which might constitute a novel intercellular communication mode. This review illustrates the current knowledge on the composition and biological functions as well as the therapeutic potential of MSC‐derived exosomes in cancer, with a focus on clinical translation opportunities. The biology and therapeutic potential of mesenchymal stem cell‐derived exosomes.
Author Xunian, Zhou
Kalluri, Raghu
AuthorAffiliation 1 Department of Cancer Biology Metastasis Research Center University of Texas MD Anderson Cancer Center Houston Texas USA
2 Department of Bioengineering Rice University Houston Texas USA
3 Department of Molecular and Cellular Biology Baylor College of Medicine Houston Texas USA
AuthorAffiliation_xml – name: 2 Department of Bioengineering Rice University Houston Texas USA
– name: 1 Department of Cancer Biology Metastasis Research Center University of Texas MD Anderson Cancer Center Houston Texas USA
– name: 3 Department of Molecular and Cellular Biology Baylor College of Medicine Houston Texas USA
Author_xml – sequence: 1
  givenname: Zhou
  orcidid: 0000-0002-3287-8913
  surname: Xunian
  fullname: Xunian, Zhou
  organization: University of Texas MD Anderson Cancer Center
– sequence: 2
  givenname: Raghu
  surname: Kalluri
  fullname: Kalluri, Raghu
  email: rkalluri@mdanderson.org
  organization: Baylor College of Medicine
BookMark eNp1kc1O3DAUhS1ExV9Z8AaR2LSLwHX8k3hTiY5Ki0TFArq2HOeGMUriwU5oZ9dH4Bn7JPUwwwIE3tiWv3vuuT77ZHvwAxJyROGEpnVqTTyhXEi2RfYo4yovAeT207nMFbBil-zHeAfAJFd8h-yyQjIlS7FHfn51vvO3y8wMTTbOMZgFTqOz2cKPOIzOdJlvsx4jDna-7NM1jthnFrvu39_HBoN7wCbDPz76BH0kH1rTRTzc7Afk1_m3m9mP_PLq-8Xs7DK3ggLLa8MrLkEoUXMDRkBRV5VAWdHKgrJFWwHULWWipcKiAqpKiUVd27qtWkUbdkC-rHUXU91jY5PTYDq9CK43Yam9cfrly-Dm-tY_6JJLVYkyCXzaCAR_P2Ecde_iaigzoJ-iLnhBk0MqWUKPX6F3fgpDGi9R6RcBoOSJOl1TNvgYA7bautGMzq_6u05T0KuodIpKP0WVKj6_qni2_xa7Uf_tOly-D-rZ2fW64j8TjaUX
CitedBy_id crossref_primary_10_3390_cancers13205212
crossref_primary_10_3390_ijms25126362
crossref_primary_10_3389_fphar_2023_1063458
crossref_primary_10_4239_wjd_v13_i12_1066
crossref_primary_10_1016_j_heliyon_2024_e37031
crossref_primary_10_1007_s10620_022_07546_0
crossref_primary_10_3389_fgene_2022_915141
crossref_primary_10_1016_j_genrep_2025_102199
crossref_primary_10_20517_evcna_2024_21
crossref_primary_10_3390_ijms24043559
crossref_primary_10_1007_s12035_024_04032_8
crossref_primary_10_1016_j_biopha_2023_114817
crossref_primary_10_3390_ijms222010980
crossref_primary_10_1007_s00266_022_03168_z
crossref_primary_10_1186_s13287_024_04087_3
crossref_primary_10_1186_s12935_021_01836_9
crossref_primary_10_1016_j_jtos_2025_01_012
crossref_primary_10_1016_j_jconrel_2022_06_026
crossref_primary_10_1038_s41392_024_02018_5
crossref_primary_10_2147_JIR_S429532
crossref_primary_10_1016_j_biopha_2023_114415
crossref_primary_10_1186_s12951_024_02650_x
crossref_primary_10_1186_s12964_024_01920_3
crossref_primary_10_1186_s13287_024_03704_5
crossref_primary_10_15283_ijsc23092
crossref_primary_10_1016_j_biopha_2023_115739
crossref_primary_10_3390_cells13231956
crossref_primary_10_1007_s11033_024_09878_8
crossref_primary_10_3390_cells14060409
crossref_primary_10_1002_1873_3468_14460
crossref_primary_10_1111_febs_15558
crossref_primary_10_1155_2022_1252557
crossref_primary_10_3390_cells13070617
crossref_primary_10_2174_011574888X268109230924233850
crossref_primary_10_1186_s13287_024_04019_1
crossref_primary_10_5812_jcma_154383
crossref_primary_10_3389_fcell_2023_1100941
crossref_primary_10_1016_j_biomaterials_2024_123001
crossref_primary_10_1210_endocr_bqaa250
crossref_primary_10_3390_ijms23062927
crossref_primary_10_1007_s11684_023_0999_5
crossref_primary_10_1016_j_mcp_2024_101958
crossref_primary_10_1016_j_intimp_2023_110121
crossref_primary_10_1080_20477724_2023_2240085
crossref_primary_10_3389_fcell_2021_734720
crossref_primary_10_3390_pharmaceutics15010021
crossref_primary_10_1016_j_vesic_2024_100053
crossref_primary_10_1016_j_canlet_2021_11_015
crossref_primary_10_3390_ijms241310917
crossref_primary_10_1111_jdi_14050
crossref_primary_10_1155_2021_3710372
crossref_primary_10_3389_fnmol_2022_868531
crossref_primary_10_1007_s12185_022_03436_3
crossref_primary_10_1177_08987564231206459
crossref_primary_10_3390_biomedicines10051179
crossref_primary_10_1155_2023_4245704
crossref_primary_10_1242_bio_060345
crossref_primary_10_3389_fcell_2021_770510
crossref_primary_10_3390_cells10102533
crossref_primary_10_3390_pharmaceutics13020232
crossref_primary_10_3390_pharmaceutics15051453
crossref_primary_10_2147_IJN_S395246
crossref_primary_10_1007_s44313_024_00051_5
crossref_primary_10_1177_09636897221133818
crossref_primary_10_3390_ijms24119356
crossref_primary_10_2147_IJN_S377317
crossref_primary_10_1016_j_intimp_2024_112171
crossref_primary_10_1055_s_0044_1786681
crossref_primary_10_1002_jgm_3596
crossref_primary_10_1016_j_rbmo_2023_06_008
crossref_primary_10_2147_IJN_S475234
crossref_primary_10_3389_fmolb_2023_1324692
crossref_primary_10_1111_odi_14375
crossref_primary_10_1186_s12951_024_02922_6
crossref_primary_10_3389_fimmu_2021_749192
crossref_primary_10_3390_ijms251910709
crossref_primary_10_1007_s12079_023_00794_3
crossref_primary_10_1016_j_cyto_2023_156386
crossref_primary_10_1016_j_omtm_2021_05_010
crossref_primary_10_4252_wjsc_v15_i7_665
crossref_primary_10_1038_s41419_022_05034_x
crossref_primary_10_1002_cbf_3908
crossref_primary_10_3389_fcell_2023_1151357
crossref_primary_10_3390_cells13040336
crossref_primary_10_1097_WNR_0000000000001941
crossref_primary_10_3389_fnagi_2022_1010562
crossref_primary_10_3390_ijms23169274
crossref_primary_10_1007_s13770_022_00513_w
crossref_primary_10_2147_IJN_S456268
crossref_primary_10_3390_ijms231810421
crossref_primary_10_3389_fphar_2023_1112743
crossref_primary_10_3389_fcvm_2021_723236
crossref_primary_10_3389_fphar_2022_928933
crossref_primary_10_1080_0886022X_2023_2177082
crossref_primary_10_1038_s41392_024_01735_1
crossref_primary_10_1007_s00011_023_01821_0
crossref_primary_10_1002_jbt_23346
crossref_primary_10_1002_jev2_12305
crossref_primary_10_1016_j_jddst_2024_106262
crossref_primary_10_1080_10717544_2022_2118898
crossref_primary_10_1016_j_semcancer_2022_04_007
crossref_primary_10_1007_s12274_022_5275_5
crossref_primary_10_1155_2021_5579904
crossref_primary_10_3389_fcell_2023_1211217
crossref_primary_10_3390_ijms24065813
crossref_primary_10_1016_j_bcp_2024_116699
crossref_primary_10_1016_j_cjtee_2023_11_002
crossref_primary_10_1016_j_ijbiomac_2025_141606
crossref_primary_10_3389_fcell_2023_1291016
crossref_primary_10_1111_cas_15400
crossref_primary_10_1186_s12951_024_02298_7
crossref_primary_10_2147_CCID_S446676
crossref_primary_10_1016_j_vesic_2024_100046
crossref_primary_10_1007_s13577_021_00646_5
crossref_primary_10_1016_j_cocis_2021_101460
crossref_primary_10_3390_cancers15184425
crossref_primary_10_1016_j_jbc_2021_100523
crossref_primary_10_3390_cancers13225662
crossref_primary_10_3390_jcm10040711
crossref_primary_10_3390_ijms252011121
crossref_primary_10_1155_2021_4758364
crossref_primary_10_3390_life13061235
crossref_primary_10_1007_s00109_022_02276_2
crossref_primary_10_1007_s00210_024_03762_9
crossref_primary_10_1016_j_lfs_2024_122542
crossref_primary_10_3390_ijms23010008
crossref_primary_10_1016_j_ijbiomac_2024_135654
crossref_primary_10_1016_j_mocell_2024_100151
crossref_primary_10_3389_fcell_2022_1115786
crossref_primary_10_3390_ph17050607
crossref_primary_10_1186_s12943_022_01650_5
crossref_primary_10_1111_ejh_14014
crossref_primary_10_2217_imt_2021_0245
crossref_primary_10_2147_IJN_S480901
crossref_primary_10_1016_j_ajt_2023_07_010
crossref_primary_10_1021_acsnano_4c11630
crossref_primary_10_1038_s41598_024_67339_5
crossref_primary_10_1007_s11033_023_08392_7
crossref_primary_10_1210_endrev_bnac009
crossref_primary_10_3389_fimmu_2023_1153901
crossref_primary_10_1155_2021_6219715
crossref_primary_10_1016_j_prp_2024_155666
crossref_primary_10_1021_acsabm_4c00089
crossref_primary_10_1002_pmic_202200107
crossref_primary_10_3390_ijms23137306
crossref_primary_10_1002_cbf_4029
crossref_primary_10_1007_s12265_023_10438_x
crossref_primary_10_1016_j_critrevonc_2024_104348
crossref_primary_10_3390_ijms241713419
crossref_primary_10_3389_fcell_2021_716853
crossref_primary_10_1007_s13577_021_00571_7
crossref_primary_10_1186_s13287_021_02378_7
crossref_primary_10_1016_j_bj_2022_01_015
crossref_primary_10_3390_ijms231810972
crossref_primary_10_3389_fmicb_2021_785622
crossref_primary_10_1080_15384047_2022_2123675
crossref_primary_10_1111_srt_13463
crossref_primary_10_1186_s12964_023_01142_z
crossref_primary_10_1007_s10557_023_07472_x
crossref_primary_10_1016_j_gene_2023_148002
crossref_primary_10_4236_scd_2024_141001
crossref_primary_10_3389_fcell_2025_1563427
Cites_doi 10.3389/fimmu.2020.00165
10.4049/jimmunol.179.8.5024
10.1186/s12943-018-0867-0
10.1038/nrm.2017.125
10.1016/j.canlet.2011.10.002
10.1016/j.jconrel.2014.11.029
10.1016/j.imlet.2012.06.001
10.2147/OTT.S173110
10.4110/in.2017.17.2.89
10.1038/nrc.2016.25
10.3389/fimmu.2018.00771
10.1080/15384101.2015.1005530
10.1038/srep38498
10.1002/jcp.26436
10.1038/mt.2008.1
10.4049/jimmunol.180.5.3081
10.1038/nri2395
10.1016/j.devcel.2011.05.015
10.1002/stem.1934
10.1007/s00125-015-3808-0
10.1016/j.ymthe.2017.03.030
10.1111/j.1582-4934.2009.00860.x
10.1242/jcs.166074
10.1021/pr200682z
10.18632/oncotarget.16778
10.3389/fimmu.2014.00556
10.3390/cancers11060798
10.1186/s13578-019-0282-2
10.3389/fimmu.2018.03053
10.1038/s41409-019-0616-z
10.1038/nri2567
10.1074/jbc.C113.532267
10.1089/scd.2013.0479
10.1038/s41586-018-0392-8
10.1007/s12015-014-9514-3
10.1038/s41419-018-0323-5
10.1007/s13402-017-0335-7
10.4049/jimmunol.1601694
10.1186/s12964-015-0124-8
10.1007/s12015-013-9436-5
10.1089/scd.2018.0015
10.1038/nri3209
10.1007/s00109-013-1020-6
10.1634/stemcells.2006-0114
10.1158/0008-5472.CAN-06-1819
10.1172/JCI66517
10.1016/j.jconrel.2014.07.042
10.1371/journal.pone.0163665
10.4049/jimmunol.1001768
10.1089/scd.2017.0087
10.1016/j.mcp.2020.101513
10.1038/aps.2017.12
10.1016/j.bbrc.2014.02.007
10.3727/096368915X689622
10.1038/ni.3002
10.3892/ijo.2015.3001
10.3389/fimmu.2018.02538
10.1161/CIRCULATIONAHA.112.114173
10.1080/20013078.2017.1265291
10.1186/s12967-014-0260-8
10.1089/scd.2016.0093
10.1126/science.aau6977
10.1242/jcs.170373
10.1038/s41388-017-0116-9
10.3390/jcm7100355
10.1038/ncb2574
10.1016/j.devcel.2016.04.019
10.1194/jlr.R084343
10.1002/adhm.201801268
10.1155/2016/1240301
10.1080/2162402X.2015.1071008
10.1016/j.cub.2018.01.059
10.1038/mtna.2011.2
10.1002/stem.2759
10.1177/0963689718805375
10.1038/ncb1596
10.3727/096368915X687543
10.1371/journal.pone.0084256
10.1016/j.cell.2014.09.051
10.1038/nature22341
10.1158/0008-5472.CAN-16-1092
10.1002/stem.2448
10.3389/fimmu.2019.01288
10.1186/s12885-015-2025-z
10.1016/j.bbrc.2019.02.005
10.1016/j.ymthe.2018.05.009
10.1007/s11010-019-03526-7
10.1038/mt.2010.105
10.1186/s13287-015-0116-z
10.18632/oncotarget.22371
10.1089/scd.2018.0200
10.1182/blood-2014-03-562439
10.1158/2326-6066.CIR-17-0581
10.1038/s41598-017-13460-7
10.3402/jev.v4.30087
10.1038/mt.2012.180
10.1186/s12943-019-0963-9
10.1038/s41598-018-19581-x
10.1073/pnas.1704862114
10.1089/scd.2014.0091
10.1016/j.cell.2019.02.016
10.1038/srep24120
10.1038/nn.3109
10.1016/j.urology.2016.01.028
10.1172/JCI81135
10.1016/S0140-6736(08)60690-X
10.3389/fbioe.2019.00292
10.1080/15384047.2017.1281499
10.1038/s41598-017-02786-x
10.1126/scisignal.2005231
10.1016/j.canlet.2013.02.019
10.1002/stem.1161
10.1007/s11010-013-1746-z
10.2217/epi-2017-0151
10.1038/ncomms2282
10.1002/jor.1100090504
10.3324/haematol.2016.163337
10.1016/j.scr.2015.02.007
ContentType Journal Article
Copyright 2020 The Authors. published by John Wiley & Sons Australia, Ltd on behalf of Japanese Cancer Association
2020. This work is published under http://creativecommons.org/licenses/by-nc/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
2020 The Authors. Cancer Science published by John Wiley & Sons Australia, Ltd on behalf of Japanese Cancer Association.
Copyright_xml – notice: 2020 The Authors. published by John Wiley & Sons Australia, Ltd on behalf of Japanese Cancer Association
– notice: 2020. This work is published under http://creativecommons.org/licenses/by-nc/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
– notice: 2020 The Authors. Cancer Science published by John Wiley & Sons Australia, Ltd on behalf of Japanese Cancer Association.
DBID 24P
AAYXX
CITATION
3V.
7X7
7XB
88E
8FE
8FH
8FI
8FJ
8FK
ABUWG
AFKRA
AZQEC
BBNVY
BENPR
BHPHI
CCPQU
DWQXO
FYUFA
GHDGH
GNUQQ
HCIFZ
K9.
LK8
M0S
M1P
M7P
PHGZM
PHGZT
PIMPY
PJZUB
PKEHL
PPXIY
PQEST
PQGLB
PQQKQ
PQUKI
PRINS
7X8
5PM
DOI 10.1111/cas.14563
DatabaseName Wiley Online Library Open Access
CrossRef
ProQuest Central (Corporate)
Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Medical Database (Alumni Edition)
ProQuest SciTech Collection
ProQuest Natural Science Collection
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni)
ProQuest Central UK/Ireland
ProQuest Central Essentials
Biological Science Database
ProQuest Central
Natural Science Collection
ProQuest One Community College
ProQuest Central Korea
Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Central Student
SciTech Premium Collection
ProQuest Health & Medical Complete (Alumni)
Biological Sciences
ProQuest Health & Medical Collection
Medical Database
Biological Science Database
ProQuest Central Premium
ProQuest One Academic
Publicly Available Content Database
ProQuest Health & Medical Research Collection
ProQuest One Academic Middle East (New)
ProQuest One Health & Nursing
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Applied & Life Sciences
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central China
MEDLINE - Academic
PubMed Central (Full Participant titles)
DatabaseTitle CrossRef
Publicly Available Content Database
ProQuest Central Student
ProQuest One Academic Middle East (New)
ProQuest Central Essentials
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
SciTech Premium Collection
ProQuest One Community College
ProQuest One Health & Nursing
ProQuest Natural Science Collection
ProQuest Central China
ProQuest Central
ProQuest One Applied & Life Sciences
ProQuest Health & Medical Research Collection
Health Research Premium Collection
Health and Medicine Complete (Alumni Edition)
Natural Science Collection
ProQuest Central Korea
Health & Medical Research Collection
Biological Science Collection
ProQuest Central (New)
ProQuest Medical Library (Alumni)
ProQuest Biological Science Collection
ProQuest One Academic Eastern Edition
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
Biological Science Database
ProQuest SciTech Collection
ProQuest Hospital Collection (Alumni)
ProQuest Health & Medical Complete
ProQuest Medical Library
ProQuest One Academic UKI Edition
ProQuest One Academic
ProQuest One Academic (New)
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList MEDLINE - Academic
Publicly Available Content Database

CrossRef

Database_xml – sequence: 1
  dbid: 24P
  name: Wiley Online Library Open Access
  url: https://authorservices.wiley.com/open-science/open-access/browse-journals.html
  sourceTypes: Publisher
– sequence: 2
  dbid: BENPR
  name: ProQuest Central
  url: https://www.proquest.com/central
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
DocumentTitleAlternate XUNIAN and KALLURI
EISSN 1349-7006
EndPage 3110
ExternalDocumentID PMC7469857
10_1111_cas_14563
CAS14563
Genre reviewArticle
GroupedDBID ---
.3N
.55
.GA
.Y3
05W
0R~
10A
1OC
24P
29B
2WC
31~
36B
3O-
4.4
50Y
50Z
51W
51X
52M
52N
52O
52P
52R
52S
52T
52W
52X
53G
5GY
5HH
5LA
5VS
66C
7.U
702
7PT
8-0
8-1
8-3
8-4
8-5
8FE
8FH
8UM
930
A01
A03
AAHHS
AAZKR
ABCQN
ABEML
ACCFJ
ACCMX
ACSCC
ACXQS
ADBBV
ADKYN
ADPDF
ADZMN
ADZOD
AEEZP
AENEX
AEQDE
AFBPY
AFEBI
AFFNX
AFKRA
AFPKN
AFZJQ
AIWBW
AJBDE
ALMA_UNASSIGNED_HOLDINGS
ALUQN
AOIJS
AVUZU
BAWUL
BBNVY
BCNDV
BENPR
BFHJK
BHPHI
BY8
CAG
CCPQU
COF
CS3
D-6
D-7
D-E
D-F
DIK
DR2
DU5
E3Z
EBS
EJD
EMB
EMOBN
EX3
F00
F01
F04
F5P
FIJ
GODZA
GROUPED_DOAJ
HCIFZ
HF~
HOLLA
HYE
HZI
HZ~
IAO
IHR
IPNFZ
ITC
IX1
J0M
K.9
K48
KQ8
LC2
LC3
LH4
LK8
LP6
LP7
LW6
M7P
MK4
N04
N05
N9A
O9-
OIG
OK1
OVD
P2P
P2X
P2Z
P4B
P4D
PIMPY
PROAC
Q11
ROL
RPM
RX1
SJN
SUPJJ
SV3
TEORI
UB1
W8V
WIN
WOW
WQJ
WRC
WXI
X7M
XG1
ZXP
~IA
~WT
7X7
88E
8FI
8FJ
AAFWJ
AAYXX
ABUWG
CITATION
FYUFA
HMCUK
M1P
PHGZM
PHGZT
PSQYO
UKHRP
3V.
7XB
8FK
AAMMB
AEFGJ
AGXDD
AIDQK
AIDYY
AZQEC
DWQXO
GNUQQ
K9.
PJZUB
PKEHL
PPXIY
PQEST
PQGLB
PQQKQ
PQUKI
PRINS
7X8
5PM
ID FETCH-LOGICAL-c5103-ba48460595b4a0a502b885e6818c09c2f800bf135f15ce901976e2bbcbf8f91d3
IEDL.DBID 7X7
ISSN 1347-9032
1349-7006
IngestDate Thu Aug 21 14:09:09 EDT 2025
Fri Jul 11 03:55:04 EDT 2025
Wed Aug 13 07:32:52 EDT 2025
Tue Jul 01 01:31:09 EDT 2025
Thu Apr 24 22:56:16 EDT 2025
Wed Jan 22 16:34:34 EST 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 9
Language English
License Attribution-NonCommercial
This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c5103-ba48460595b4a0a502b885e6818c09c2f800bf135f15ce901976e2bbcbf8f91d3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
ObjectType-Review-3
content type line 23
ORCID 0000-0002-3287-8913
OpenAccessLink https://www.proquest.com/docview/2439600074?pq-origsite=%requestingapplication%
PMID 32639675
PQID 2439600074
PQPubID 4378882
PageCount 11
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_7469857
proquest_miscellaneous_2421460163
proquest_journals_2439600074
crossref_citationtrail_10_1111_cas_14563
crossref_primary_10_1111_cas_14563
wiley_primary_10_1111_cas_14563_CAS14563
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate September 2020
PublicationDateYYYYMMDD 2020-09-01
PublicationDate_xml – month: 09
  year: 2020
  text: September 2020
PublicationDecade 2020
PublicationPlace Tokyo
PublicationPlace_xml – name: Tokyo
– name: Hoboken
PublicationTitle Cancer science
PublicationYear 2020
Publisher John Wiley & Sons, Inc
John Wiley and Sons Inc
Publisher_xml – name: John Wiley & Sons, Inc
– name: John Wiley and Sons Inc
References 2018; 560
2010; 14
2010; 18
2019; 11
2019; 10
2013; 123
2010; 185
1999; 284
2019; 18
2016; 2016
2020; 11
2012; 15
2012; 14
2012; 126
2013; 8
2012; 12
2012; 11
2016; 37
2014; 23
2013; 9
2016; 34
2018; 7
2018; 6
2018; 9
2018; 8
2007; 179
2018; 3
2006; 24
2019; 28
2014; 15
2007; 9
2014; 12
2018; 37
2014; 10
2018; 36
2014; 124
2019; 8
2019; 7
2018; 28
2019; 9
2013; 91
2015; 128
2016; 91
2016; 16
2016; 14
2018; 27
2014; 159
2018; 26
2012; 30
2016; 11
2018; 19
2016; 5
2016; 6
2018; 17
2018; 233
2013; 335
2019; 458
2018; 11
2018; 10
2016; 25
2019; 177
2008; 371
2017; 546
2017; 40
2017; 6
2017; 7
2017; 8
2013; 21
2019; 54
2015; 33
2016; 76
2008; 8
2020; 367
2017; 198
2017; 114
2015; 47
2019; 60
2014; 5
2020; 51
2006; 66
2017; 38
2011; 21
2019; 510
2014; 7
2014; 445
2014; 289
2015; 15
2015; 14
2015; 6
2015; 4
2017; 26
2017; 25
2016; 129
2008; 16
2013; 383
2016; 126
2014; 192
2015; 205
2012; 147
2016; 59
2015; 24
2008; 180
2012; 3
2012; 1
2017; 17
2009; 9
2017; 18
2017; 102
2012; 315
e_1_2_6_114_1
e_1_2_6_53_1
e_1_2_6_76_1
e_1_2_6_95_1
e_1_2_6_118_1
e_1_2_6_30_1
e_1_2_6_72_1
e_1_2_6_91_1
e_1_2_6_110_1
e_1_2_6_19_1
e_1_2_6_11_1
e_1_2_6_34_1
e_1_2_6_15_1
e_1_2_6_38_1
e_1_2_6_99_1
e_1_2_6_64_1
e_1_2_6_87_1
e_1_2_6_106_1
e_1_2_6_41_1
e_1_2_6_60_1
e_1_2_6_83_1
e_1_2_6_121_1
e_1_2_6_102_1
e_1_2_6_9_1
e_1_2_6_5_1
e_1_2_6_49_1
e_1_2_6_22_1
e_1_2_6_45_1
e_1_2_6_26_1
e_1_2_6_68_1
e_1_2_6_73_1
e_1_2_6_54_1
e_1_2_6_96_1
e_1_2_6_117_1
e_1_2_6_31_1
e_1_2_6_50_1
e_1_2_6_92_1
Yousafzai NA (e_1_2_6_57_1) 2018; 8
e_1_2_6_113_1
e_1_2_6_35_1
e_1_2_6_12_1
e_1_2_6_39_1
e_1_2_6_77_1
e_1_2_6_16_1
e_1_2_6_58_1
e_1_2_6_84_1
e_1_2_6_42_1
e_1_2_6_105_1
e_1_2_6_65_1
e_1_2_6_80_1
e_1_2_6_109_1
e_1_2_6_61_1
e_1_2_6_120_1
e_1_2_6_101_1
e_1_2_6_6_1
e_1_2_6_23_1
e_1_2_6_2_1
e_1_2_6_88_1
e_1_2_6_27_1
e_1_2_6_46_1
e_1_2_6_69_1
e_1_2_6_51_1
e_1_2_6_74_1
e_1_2_6_97_1
e_1_2_6_116_1
e_1_2_6_32_1
e_1_2_6_70_1
e_1_2_6_93_1
e_1_2_6_112_1
e_1_2_6_13_1
e_1_2_6_36_1
e_1_2_6_59_1
e_1_2_6_17_1
e_1_2_6_55_1
e_1_2_6_78_1
e_1_2_6_62_1
e_1_2_6_85_1
e_1_2_6_104_1
e_1_2_6_43_1
e_1_2_6_81_1
e_1_2_6_20_1
e_1_2_6_108_1
e_1_2_6_7_1
e_1_2_6_24_1
e_1_2_6_3_1
e_1_2_6_66_1
e_1_2_6_89_1
e_1_2_6_28_1
e_1_2_6_47_1
e_1_2_6_52_1
e_1_2_6_98_1
e_1_2_6_115_1
e_1_2_6_75_1
e_1_2_6_10_1
e_1_2_6_94_1
e_1_2_6_119_1
e_1_2_6_71_1
e_1_2_6_90_1
e_1_2_6_111_1
e_1_2_6_14_1
e_1_2_6_33_1
e_1_2_6_18_1
e_1_2_6_56_1
e_1_2_6_37_1
e_1_2_6_79_1
e_1_2_6_103_1
e_1_2_6_63_1
e_1_2_6_86_1
e_1_2_6_21_1
e_1_2_6_107_1
e_1_2_6_40_1
e_1_2_6_82_1
e_1_2_6_8_1
Mendt M (e_1_2_6_100_1) 2018; 3
e_1_2_6_4_1
e_1_2_6_25_1
e_1_2_6_48_1
e_1_2_6_29_1
e_1_2_6_44_1
e_1_2_6_67_1
References_xml – volume: 11
  start-page: 839
  year: 2012
  end-page: 849
  article-title: Proteomic analysis of microvesicles derived from human mesenchymal stem cells
  publication-title: J Proteome Res
– volume: 6
  start-page: 24120
  year: 2016
  article-title: Differential and transferable modulatory effects of mesenchymal stromal cell‐derived extracellular vesicles on T, B and NK cell functions
  publication-title: Sci Rep
– volume: 18
  start-page: 1606
  year: 2010
  end-page: 1614
  article-title: A novel nanoparticle drug delivery system: the anti–inflammatory activity of curcumin is enhanced when encapsulated in exosomes
  publication-title: Mol Ther
– volume: 1
  year: 2012
  article-title: miR‐1289 and "Zipcode"‐like sequence enrich mRNAs in microvesicles
  publication-title: Mol Ther Nucleic Acids
– volume: 18
  start-page: 52
  year: 2019
  article-title: Mechanisms associated with biogenesis of exosomes in cancer
  publication-title: Mol Cancer
– volume: 16
  start-page: 201
  year: 2016
  end-page: 218
  article-title: Targeting metastasis
  publication-title: Nat Rev Cancer
– volume: 7
  start-page: ra63
  year: 2014
  article-title: Exosomes from bone marrow mesenchymal stem cells contain a microRNA that promotes dormancy in metastatic breast cancer cells
  publication-title: Sci Signal
– volume: 9
  start-page: 642
  year: 2013
  end-page: 654
  article-title: Wnt signaling behaves as a "master regulator" in the osteogenic and adipogenic commitment of human amniotic fluid mesenchymal stem cells
  publication-title: Stem Cell Rev Rep
– volume: 8
  start-page: 2210
  year: 2018
  end-page: 2226
  article-title: Exosome mediated multidrug resistance in cancer
  publication-title: Am J Cancer Res
– volume: 14
  start-page: 2473
  year: 2015
  end-page: 2483
  article-title: Exosomes derived from human mesenchymal stem cells confer drug resistance in gastric cancer
  publication-title: Cell Cycle
– volume: 25
  start-page: 1269
  year: 2017
  end-page: 1278
  article-title: Engineered exosomes as vehicles for biologically active proteins
  publication-title: Mol Ther
– volume: 159
  start-page: 499
  year: 2014
  end-page: 513
  article-title: Exosome transfer from stromal to breast cancer cells regulates therapy resistance pathways
  publication-title: Cell
– volume: 7
  start-page: 292
  year: 2019
  article-title: Hypoxia conditioned mesenchymal stem cell‐derived extracellular vesicles induce increased vascular tube formation in vitro
  publication-title: Front Bioeng Biotechnol
– volume: 9
  start-page: 19
  year: 2019
  article-title: Exosomes: biogenesis, biologic function and clinical potential
  publication-title: Cell Biosci
– volume: 289
  start-page: 3869
  year: 2014
  end-page: 3875
  article-title: Identification of double‐stranded genomic DNA spanning all chromosomes with mutated KRAS and p53 DNA in the serum exosomes of patients with pancreatic cancer
  publication-title: J Biol Chem
– volume: 14
  start-page: 356
  year: 2015
  end-page: 368
  article-title: Regulation of mesenchymal stromal cells through fine tuning of canonical Wnt signaling
  publication-title: Stem Cell Res
– volume: 7
  start-page: 13162
  year: 2017
  article-title: Mesenchymal stem cells from tumor microenvironment favour breast cancer stem cell proliferation, cancerogenic and metastatic potential, via ionotropic purinergic signalling
  publication-title: Sci Rep
– volume: 124
  start-page: 555
  year: 2014
  end-page: 566
  article-title: Bone marrow stromal cell‐derived exosomes as communicators in drug resistance in multiple myeloma cells
  publication-title: Blood
– volume: 19
  start-page: 213
  year: 2018
  end-page: 228
  article-title: Shedding light on the cell biology of extracellular vesicles
  publication-title: Nat Rev Mol Cell Biol
– volume: 335
  start-page: 201
  year: 2013
  end-page: 204
  article-title: Exosomes from marrow stromal cells expressing miR‐146b inhibit glioma growth
  publication-title: Cancer Lett
– volume: 26
  start-page: 1384
  year: 2017
  end-page: 1398
  article-title: Bone marrow mesenchymal stem cell‐derived CD63(+) exosomes transport wnt3a exteriorly and enhance dermal fibroblast proliferation, migration, and angiogenesis in vitro
  publication-title: Stem Cells Dev
– volume: 383
  start-page: 13
  year: 2013
  end-page: 20
  article-title: Exosomes from human adipose‐derived mesenchymal stem cells promote migration through Wnt signaling pathway in a breast cancer cell model
  publication-title: Mol Cell Biochem
– volume: 9
  start-page: 654
  year: 2007
  end-page: 659
  article-title: Exosome‐mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells
  publication-title: Nat Cell Biol
– volume: 284
  start-page: 143
  year: 1999
  end-page: 147
  article-title: Multilineage potential of adult human mesenchymal stem cells
  publication-title: Science
– volume: 24
  start-page: 2840
  year: 2006
  end-page: 2850
  article-title: Isolation and characterization of a stem cell population from adult human liver
  publication-title: Stem Cells
– volume: 560
  start-page: 382
  year: 2018
  end-page: 386
  article-title: Exosomal PD‐L1 contributes to immunosuppression and is associated with anti–PD‐1 response
  publication-title: Nature
– volume: 129
  start-page: 2182
  year: 2016
  end-page: 2189
  article-title: Exosomes secreted by mesenchymal stem cells promote endothelial cell angiogenesis by transferring miR‐125a
  publication-title: J Cell Sci
– volume: 5
  year: 2016
  article-title: Dendritic cell‐derived exosomes as maintenance immunotherapy after first line chemotherapy in NSCLC
  publication-title: Oncoimmunology
– volume: 28
  start-page: R435
  year: 2018
  end-page: R444
  article-title: Exosomes and ectosomes in intercellular communication
  publication-title: Curr Biol
– volume: 147
  start-page: 47
  year: 2012
  end-page: 54
  article-title: Microvesicles derived from mesenchymal stem cells: potent organelles for induction of tolerogenic signaling
  publication-title: Immunol Lett
– volume: 10
  start-page: 1288
  year: 2019
  article-title: Immunomodulatory effect of MSC on B cells is independent of secreted extracellular vesicles
  publication-title: Front Immunol
– volume: 14
  start-page: 2
  year: 2016
  article-title: MSC surface markers (CD44, CD73, and CD90) can identify human MSC‐derived extracellular vesicles by conventional flow cytometry
  publication-title: Cell Commun Signal
– volume: 25
  start-page: 829
  year: 2016
  end-page: 848
  article-title: Clinical trials with mesenchymal stem cells: an update
  publication-title: Cell Transplant
– volume: 14
  start-page: 1605
  year: 2010
  end-page: 1618
  article-title: Human liver stem cell‐derived microvesicles accelerate hepatic regeneration in hepatectomized rats
  publication-title: J Cell Mol Med
– volume: 9
  start-page: 2538
  year: 2018
  article-title: Mesenchymal stromal cell‐derived extracellular vesicles attenuate dendritic cell maturation and function
  publication-title: Front Immunol
– volume: 6
  start-page: 1265291
  year: 2017
  article-title: TRAIL delivery by MSC‐derived extracellular vesicles is an effective anticancer therapy
  publication-title: J Extracell Vesicles
– volume: 34
  start-page: 2943
  year: 2016
  end-page: 2955
  article-title: Human mesenchymal stem cell‐derived microvesicles prevent the rupture of intracranial aneurysm in part by suppression of mast cell activation via a PGE2‐dependent mechanism
  publication-title: Stem Cells
– volume: 28
  start-page: 44
  year: 2019
  end-page: 55
  article-title: Human fetal liver mesenchymal stem cell‐derived exosomes impair natural killer cell function
  publication-title: Stem Cells Dev
– volume: 10
  start-page: 573
  year: 2014
  end-page: 586
  article-title: Human Wharton's jelly stem cells, its conditioned medium and cell‐free lysate inhibit the growth of human lymphoma cells
  publication-title: Stem Cell Rev Rep
– volume: 315
  start-page: 28
  year: 2012
  end-page: 37
  article-title: Exosomes derived from human bone marrow mesenchymal stem cells promote tumor growth in vivo
  publication-title: Cancer Lett
– volume: 14
  start-page: 1036
  year: 2012
  end-page: 1045
  article-title: Active Wnt proteins are secreted on exosomes
  publication-title: Nat Cell Biol
– volume: 59
  start-page: 325
  year: 2016
  end-page: 333
  article-title: Human mesenchymal stem cells and derived extracellular vesicles induce regulatory dendritic cells in type 1 diabetic patients
  publication-title: Diabetologia
– volume: 23
  start-page: 2591
  year: 2014
  end-page: 2599
  article-title: Microvescicles derived from mesenchymal stromal cells are not as effective as their cellular counterpart in the ability to modulate immune responses in vitro
  publication-title: Stem Cells Dev
– volume: 40
  start-page: 457
  year: 2017
  end-page: 470
  article-title: MicroRNA‐100 shuttled by mesenchymal stem cell‐derived exosomes suppresses in vitro angiogenesis through modulating the mTOR/HIF‐1alpha/VEGF signaling axis in breast cancer cells
  publication-title: Cell Oncol
– volume: 27
  start-page: 1657
  year: 2018
  end-page: 1683
  article-title: Exosomes derived from IDO1‐overexpressing rat bone marrow mesenchymal stem cells promote immunotolerance of cardiac allografts
  publication-title: Cell Transplant
– volume: 11
  start-page: 5753
  year: 2018
  end-page: 5762
  article-title: Targeted cancer therapy using engineered exosome as a natural drug delivery vehicle
  publication-title: Onco Targets Ther
– volume: 7
  start-page: 355
  year: 2018
  article-title: Clinical application of mesenchymal stem cell‐derived extracellular vesicle‐based therapeutics for inflammatory lung diseases
  publication-title: J Clin Med
– volume: 367
  issue: 6478
  year: 2020
  article-title: The biology, function, and biomedical applications of exosomes
  publication-title: Science
– volume: 11
  start-page: 165
  year: 2020
  article-title: Released exosomes contribute to the immune modulation of cord blood‐derived stem cells
  publication-title: Front Immunol
– volume: 51
  start-page: 101513
  year: 2020
  article-title: Exosomes derived from human bone marrow mesenchymal stem cells transfer miR‐222‐3p to suppress acute myeloid leukemia cell proliferation by targeting IRF2/INPP4B
  publication-title: Mol Cell Probes
– volume: 128
  start-page: 3171
  year: 2015
  end-page: 3176
  article-title: Cellular functions of Rab GTPases at a glance
  publication-title: J Cell Sci
– volume: 546
  start-page: 498
  year: 2017
  end-page: 503
  article-title: Exosomes facilitate therapeutic targeting of oncogenic KRAS in pancreatic cancer
  publication-title: Nature
– volume: 30
  start-page: 1985
  year: 2012
  end-page: 1998
  article-title: Human liver stem cell‐derived microvesicles inhibit hepatoma growth in SCID mice by delivering antitumor microRNAs
  publication-title: Stem Cells
– volume: 66
  start-page: 9290
  year: 2006
  end-page: 9298
  article-title: Human tumor‐released microvesicles promote the differentiation of myeloid cells with transforming growth factor‐beta‐mediated suppressive activity on T lymphocytes
  publication-title: Cancer Res
– volume: 126
  start-page: 1208
  year: 2016
  end-page: 1215
  article-title: The biology and function of exosomes in cancer
  publication-title: J Clin Invest
– volume: 458
  start-page: 11
  year: 2019
  end-page: 26
  article-title: Exosomes derived from microRNA‐101‐3p‐overexpressing human bone marrow mesenchymal stem cells suppress oral cancer cell proliferation, invasion, and migration
  publication-title: Mol Cell Biochem
– volume: 8
  start-page: 109861
  year: 2017
  end-page: 109876
  article-title: Stromal cell extracellular vesicular cargo mediated regulation of breast cancer cell metastasis via ubiquitin conjugating enzyme E2 N pathway
  publication-title: Oncotarget
– volume: 3
  year: 2018
  article-title: Generation and testing of clinical‐grade exosomes for pancreatic cancer. JCI
  publication-title: Insight
– volume: 205
  start-page: 35
  year: 2015
  end-page: 44
  article-title: Active loading into extracellular vesicles significantly improves the cellular uptake and photodynamic effect of porphyrins
  publication-title: J Control Release
– volume: 26
  start-page: 1610
  year: 2018
  end-page: 1623
  article-title: Mesenchymal stem cell‐based therapy for cardiovascular disease: progress and challenges
  publication-title: Mol Ther
– volume: 8
  year: 2013
  article-title: Exosomes derived from mesenchymal stem cells suppress angiogenesis by down‐regulating VEGF expression in breast cancer cells
  publication-title: PLoS One
– volume: 177
  start-page: 414
  year: 2019
  end-page: 427.e13
  article-title: Suppression of exosomal PD‐L1 induces systemic anti–tumor immunity and memory
  publication-title: Cell
– volume: 18
  start-page: 158
  year: 2017
  end-page: 165
  article-title: Detection of mutant KRAS and TP53 DNA in circulating exosomes from healthy individuals and patients with pancreatic cancer
  publication-title: Cancer Biol Ther
– volume: 16
  start-page: 782
  year: 2008
  end-page: 790
  article-title: Phase I clinical trial of autologous ascites‐derived exosomes combined with GM‐CSF for colorectal cancer
  publication-title: Mol Ther
– volume: 54
  start-page: 789
  issue: Suppl 2
  year: 2019
  end-page: 792
  article-title: Mesenchymal stem cell‐derived exosomes for clinical use
  publication-title: Bone Marrow Transplant
– volume: 8
  start-page: 45200
  year: 2017
  end-page: 45212
  article-title: Mesenchymal stem cells release exosomes that transfer miRNAs to endothelial cells and promote angiogenesis
  publication-title: Oncotarget
– volume: 36
  start-page: 434
  year: 2018
  end-page: 445
  article-title: Graft‐Versus‐Host disease amelioration by human bone marrow mesenchymal stromal/stem cell‐derived extracellular vesicles is associated with peripheral preservation of naive T cell populations
  publication-title: Stem Cells
– volume: 3
  start-page: 1282
  year: 2012
  article-title: Delivery of chemotherapeutic drugs in tumour cell‐derived microparticles
  publication-title: Nat Commun
– volume: 126
  start-page: 2601
  year: 2012
  end-page: 2611
  article-title: Exosomes mediate the cytoprotective action of mesenchymal stromal cells on hypoxia‐induced pulmonary hypertension
  publication-title: Circulation
– volume: 102
  start-page: 1594
  year: 2017
  end-page: 1604
  article-title: Extracellular vesicles of bone marrow stromal cells rescue chronic lymphocytic leukemia B cells from apoptosis, enhance their migration and induce gene expression modifications
  publication-title: Haematologica
– volume: 11
  start-page: 798
  year: 2019
  article-title: Taxol‐loaded MSC‐derived exosomes provide a therapeutic vehicle to target metastatic breast cancer and other carcinoma cells
  publication-title: Cancers
– volume: 91
  year: 2016
  article-title: PLK‐1 Silencing in bladder cancer by siRNA delivered with exosomes
  publication-title: Urology
– volume: 15
  start-page: 862
  year: 2012
  end-page: 870
  article-title: Hepatocyte growth factor mediates mesenchymal stem cell‐induced recovery in multiple sclerosis models
  publication-title: Nat Neurosci
– volume: 371
  start-page: 1579
  year: 2008
  end-page: 1586
  article-title: Mesenchymal stem cells for treatment of steroid‐resistant, severe, acute graft‐versus‐host disease: a phase II study
  publication-title: Lancet
– volume: 60
  start-page: 9
  year: 2019
  end-page: 18
  article-title: Exosomal lipid composition and the role of ether lipids and phosphoinositides in exosome biology
  publication-title: J Lipid Res
– volume: 233
  start-page: 6832
  year: 2018
  end-page: 6840
  article-title: Exosomes originating from MSCs stimulated with TGF‐beta and IFN‐gamma promote Treg differentiation
  publication-title: J Cell Physiol
– volume: 21
  start-page: 77
  year: 2011
  end-page: 91
  article-title: The ESCRT pathway
  publication-title: Dev Cell
– volume: 445
  start-page: 381
  year: 2014
  end-page: 387
  article-title: Exosome‐formed synthetic microRNA‐143 is transferred to osteosarcoma cells and inhibits their migration
  publication-title: Biochem Biophys Res Commun
– volume: 179
  start-page: 5024
  year: 2007
  end-page: 5032
  article-title: Antigen presentation by exosomes released from peptide‐pulsed dendritic cells is not suppressed by the presence of active CTL
  publication-title: J Immunol
– volume: 123
  start-page: 1542
  year: 2013
  end-page: 1555
  article-title: BM mesenchymal stromal cell‐derived exosomes facilitate multiple myeloma progression
  publication-title: J Clin Invest
– volume: 2016
  start-page: 1240301
  year: 2016
  article-title: CCR2 positive exosome released by mesenchymal stem cells suppresses macrophage functions and alleviates ischemia/reperfusion‐induced renal injury
  publication-title: Stem Cells Int
– volume: 21
  start-page: 185
  year: 2013
  end-page: 191
  article-title: Systemically injected exosomes targeted to EGFR deliver antitumor microRNA to breast cancer cells
  publication-title: Mol Ther
– volume: 15
  start-page: 1009
  year: 2015
  article-title: Role of HLA‐G and extracellular vesicles in renal cancer stem cell‐induced inhibition of dendritic cell differentiation
  publication-title: BMC Cancer
– volume: 17
  start-page: 89
  year: 2017
  end-page: 102
  article-title: Mesenchymal stromal cells and toll‐like receptor priming: a critical review
  publication-title: Immune Netw
– volume: 7
  start-page: 2552
  year: 2017
  article-title: Exosomes derived from human umbilical cord mesenchymal stem cells protect against cisplatin‐induced ovarian granulosa cell stress and apoptosis in vitro
  publication-title: Sci Rep
– volume: 180
  start-page: 3081
  year: 2008
  end-page: 3090
  article-title: Exosomes as a short‐range mechanism to spread alloantigen between dendritic cells during T cell allorecognition
  publication-title: J Immunol
– volume: 9
  start-page: 771
  year: 2018
  article-title: Mesenchymal stromal cells and their extracellular vesicles enhance the anti–inflammatory phenotype of regulatory macrophages by downregulating the production of interleukin (IL)‐23 and IL‐22
  publication-title: Front Immunol
– volume: 9
  start-page: 3053
  year: 2018
  article-title: Mesenchymal stromal cell‐derived exosomes affect mRNA expression and function of B‐lymphocytes
  publication-title: Front Immunol
– volume: 37
  start-page: 301
  year: 2016
  end-page: 309
  article-title: Extracellular vesicles: satellites of information transfer in cancer and stem cell biology
  publication-title: Dev Cell
– volume: 8
  year: 2019
  article-title: Exploiting exosomes in cancer liquid biopsies and drug delivery
  publication-title: Adv Healthc Mater
– volume: 9
  start-page: 581
  year: 2009
  end-page: 593
  article-title: Membrane vesicles as conveyors of immune responses
  publication-title: Nat Rev Immunol
– volume: 4
  start-page: 30087
  year: 2015
  article-title: Applying extracellular vesicles based therapeutics in clinical trials ‐ an ISEV position paper
  publication-title: J Extracell Vesicles
– volume: 25
  start-page: 1290
  year: 2016
  end-page: 1298
  article-title: microRNA‐145 mediates the inhibitory effect of adipose tissue‐derived stromal cells on prostate cancer
  publication-title: Stem Cells Dev
– volume: 5
  start-page: 556
  year: 2014
  article-title: Immunomodulatory potential of human adipose mesenchymal stem cells derived exosomes on in vitro stimulated T cells
  publication-title: Front Immunol
– volume: 76
  start-page: 5832
  year: 2016
  end-page: 5844
  article-title: Mesenchymal stem cell‐derived exosomes stimulate cycling quiescence and early breast cancer dormancy in bone marrow
  publication-title: Cancer Res
– volume: 114
  year: 2017
  article-title: Packaging and transfer of mitochondrial DNA via exosomes regulate escape from dormancy in hormonal therapy‐resistant breast cancer
  publication-title: Proc Natl Acad Sci USA
– volume: 9
  start-page: 218
  year: 2018
  article-title: Human umbilical cord mesenchymal stem cell‐derived extracellular vesicles promote lung adenocarcinoma growth by transferring miR‐410
  publication-title: Cell Death Dis
– volume: 6
  start-page: 910
  year: 2018
  end-page: 920
  article-title: Exosomes shuttle TREX1‐sensitive IFN‐stimulatory dsDNA from irradiated cancer cells to DCs
  publication-title: Cancer Immunol Res
– volume: 15
  start-page: 1009
  year: 2014
  end-page: 1016
  article-title: Plasticity of mesenchymal stem cells in immunomodulation: pathological and therapeutic implications
  publication-title: Nat Immunol
– volume: 12
  start-page: 260
  year: 2014
  article-title: A review of therapeutic effects of mesenchymal stem cell secretions and induction of secretory modification by different culture methods
  publication-title: J Transl Med
– volume: 17
  start-page: 122
  year: 2018
  article-title: Exosomes derived from mesenchymal stem cells enhance radiotherapy‐induced cell death in tumor and metastatic tumor foci
  publication-title: Mol Cancer
– volume: 8
  start-page: 1419
  year: 2018
  article-title: The microRNA regulatory landscape of MSC‐derived exosomes: a systems view
  publication-title: Sci Rep
– volume: 24
  start-page: 2615
  year: 2015
  end-page: 2627
  article-title: Immunoregulatory effects of mesenchymal stem cell‐derived extracellular vesicles on T lymphocytes
  publication-title: Cell Transplant
– volume: 91
  start-page: 431
  year: 2013
  end-page: 437
  article-title: Exosomes in tumor microenvironment influence cancer progression and metastasis
  publication-title: J Mol Med
– volume: 33
  start-page: 1200
  year: 2015
  end-page: 1212
  article-title: Bone marrow‐derived mesenchymal stromal cells harness purinergenic signaling to tolerize human Th1 cells in vivo
  publication-title: Stem Cells
– volume: 28
  start-page: 398
  year: 2019
  end-page: 409
  article-title: Exosomes derived from human primed mesenchymal stem cells induce mitosis and potentiate growth factor secretion
  publication-title: Stem Cells Dev
– volume: 47
  start-page: 244
  year: 2015
  end-page: 252
  article-title: Acquisition of new tumor cell properties by MSC‐derived exosomes
  publication-title: Int J Oncol
– volume: 6
  start-page: 127
  year: 2015
  article-title: Human bone marrow‐ and adipose‐mesenchymal stem cells secrete exosomes enriched in distinctive miRNA and tRNA species
  publication-title: Stem Cell Res Ther
– volume: 10
  start-page: 1499
  year: 2018
  end-page: 1509
  article-title: Exosome: a novel mediator in drug resistance of cancer cells
  publication-title: Epigenomics
– volume: 23
  start-page: 1233
  year: 2014
  end-page: 1244
  article-title: Mesenchymal stem cells secrete immunologically active exosomes
  publication-title: Stem Cells Dev
– volume: 11
  year: 2016
  article-title: Indication of horizontal DNA gene transfer by extracellular vesicles
  publication-title: PLoS One
– volume: 12
  start-page: 383
  year: 2012
  end-page: 396
  article-title: Multipotent mesenchymal stromal cells and the innate immune system
  publication-title: Nat Rev Immunol
– volume: 185
  start-page: 6608
  year: 2010
  end-page: 6616
  article-title: Exosome‐driven antigen transfer for MHC class II presentation facilitated by the receptor binding activity of influenza hemagglutinin
  publication-title: J Immunol
– volume: 37
  start-page: 2137
  year: 2018
  end-page: 2149
  article-title: Employing mesenchymal stem cells to support tumor‐targeted delivery of extracellular vesicle (EV)‐encapsulated microRNA‐379
  publication-title: Oncogene
– volume: 192
  start-page: 262
  year: 2014
  end-page: 270
  article-title: Paclitaxel is incorporated by mesenchymal stromal cells and released in exosomes that inhibit in vitro tumor growth: a new approach for drug delivery
  publication-title: J Control Release
– volume: 510
  start-page: 565
  year: 2019
  end-page: 572
  article-title: Exosomes derived from mesenchymal stem cells attenuate the progression of atherosclerosis in ApoE(‐/‐) mice via miR‐let7 mediated infiltration and polarization of M2 macrophage
  publication-title: Biochem Biophys Res Commun
– volume: 8
  start-page: 726
  year: 2008
  end-page: 736
  article-title: Mesenchymal stem cells in health and disease
  publication-title: Nat Rev Immunol
– volume: 6
  start-page: 38498
  year: 2016
  article-title: Human adipose mesenchymal stem cell‐derived exosomal‐miRNAs are critical factors for inducing anti–proliferation signalling to A2780 and SKOV‐3 ovarian cancer cells
  publication-title: Sci Rep
– volume: 198
  start-page: 1649
  year: 2017
  end-page: 1659
  article-title: DNA‐containing exosomes derived from cancer cells treated with topotecan activate a STING‐dependent pathway and reinforce antitumor immunity
  publication-title: J Immunol
– volume: 38
  start-page: 754
  year: 2017
  end-page: 763
  article-title: Engineering exosomes as refined biological nanoplatforms for drug delivery
  publication-title: Acta Pharmacol Sin
– ident: e_1_2_6_92_1
  doi: 10.3389/fimmu.2020.00165
– ident: e_1_2_6_65_1
  doi: 10.4049/jimmunol.179.8.5024
– ident: e_1_2_6_51_1
  doi: 10.1186/s12943-018-0867-0
– ident: e_1_2_6_11_1
  doi: 10.1038/nrm.2017.125
– ident: e_1_2_6_38_1
  doi: 10.1016/j.canlet.2011.10.002
– ident: e_1_2_6_107_1
  doi: 10.1016/j.jconrel.2014.11.029
– ident: e_1_2_6_75_1
  doi: 10.1016/j.imlet.2012.06.001
– ident: e_1_2_6_111_1
  doi: 10.2147/OTT.S173110
– ident: e_1_2_6_89_1
  doi: 10.4110/in.2017.17.2.89
– ident: e_1_2_6_49_1
  doi: 10.1038/nrc.2016.25
– ident: e_1_2_6_88_1
  doi: 10.3389/fimmu.2018.00771
– ident: e_1_2_6_63_1
  doi: 10.1080/15384101.2015.1005530
– ident: e_1_2_6_36_1
  doi: 10.1038/srep38498
– ident: e_1_2_6_93_1
  doi: 10.1002/jcp.26436
– ident: e_1_2_6_113_1
  doi: 10.1038/mt.2008.1
– ident: e_1_2_6_68_1
  doi: 10.4049/jimmunol.180.5.3081
– ident: e_1_2_6_118_1
  doi: 10.1038/nri2395
– ident: e_1_2_6_9_1
  doi: 10.1016/j.devcel.2011.05.015
– ident: e_1_2_6_77_1
  doi: 10.1002/stem.1934
– ident: e_1_2_6_80_1
  doi: 10.1007/s00125-015-3808-0
– ident: e_1_2_6_102_1
  doi: 10.1016/j.ymthe.2017.03.030
– ident: e_1_2_6_27_1
  doi: 10.1111/j.1582-4934.2009.00860.x
– ident: e_1_2_6_12_1
  doi: 10.1242/jcs.166074
– ident: e_1_2_6_20_1
  doi: 10.1021/pr200682z
– ident: e_1_2_6_43_1
  doi: 10.18632/oncotarget.16778
– ident: e_1_2_6_91_1
  doi: 10.3389/fimmu.2014.00556
– ident: e_1_2_6_112_1
  doi: 10.3390/cancers11060798
– ident: e_1_2_6_18_1
  doi: 10.1186/s13578-019-0282-2
– ident: e_1_2_6_85_1
  doi: 10.3389/fimmu.2018.03053
– ident: e_1_2_6_121_1
  doi: 10.1038/s41409-019-0616-z
– ident: e_1_2_6_67_1
  doi: 10.1038/nri2567
– ident: e_1_2_6_6_1
  doi: 10.1074/jbc.C113.532267
– ident: e_1_2_6_90_1
  doi: 10.1089/scd.2013.0479
– ident: e_1_2_6_71_1
  doi: 10.1038/s41586-018-0392-8
– ident: e_1_2_6_34_1
  doi: 10.1007/s12015-014-9514-3
– ident: e_1_2_6_40_1
  doi: 10.1038/s41419-018-0323-5
– ident: e_1_2_6_48_1
  doi: 10.1007/s13402-017-0335-7
– ident: e_1_2_6_30_1
  doi: 10.4049/jimmunol.1601694
– ident: e_1_2_6_19_1
  doi: 10.1186/s12964-015-0124-8
– ident: e_1_2_6_14_1
  doi: 10.1007/s12015-013-9436-5
– ident: e_1_2_6_78_1
  doi: 10.1089/scd.2018.0015
– ident: e_1_2_6_116_1
  doi: 10.1038/nri3209
– ident: e_1_2_6_50_1
  doi: 10.1007/s00109-013-1020-6
– ident: e_1_2_6_26_1
  doi: 10.1634/stemcells.2006-0114
– ident: e_1_2_6_70_1
  doi: 10.1158/0008-5472.CAN-06-1819
– ident: e_1_2_6_39_1
  doi: 10.1172/JCI66517
– ident: e_1_2_6_106_1
  doi: 10.1016/j.jconrel.2014.07.042
– ident: e_1_2_6_31_1
  doi: 10.1371/journal.pone.0163665
– ident: e_1_2_6_64_1
  doi: 10.4049/jimmunol.1001768
– ident: e_1_2_6_45_1
  doi: 10.1089/scd.2017.0087
– ident: e_1_2_6_32_1
  doi: 10.1016/j.mcp.2020.101513
– ident: e_1_2_6_108_1
  doi: 10.1038/aps.2017.12
– ident: e_1_2_6_53_1
  doi: 10.1016/j.bbrc.2014.02.007
– ident: e_1_2_6_120_1
  doi: 10.3727/096368915X689622
– ident: e_1_2_6_3_1
  doi: 10.1038/ni.3002
– ident: e_1_2_6_42_1
  doi: 10.3892/ijo.2015.3001
– ident: e_1_2_6_82_1
  doi: 10.3389/fimmu.2018.02538
– ident: e_1_2_6_44_1
  doi: 10.1161/CIRCULATIONAHA.112.114173
– ident: e_1_2_6_103_1
  doi: 10.1080/20013078.2017.1265291
– ident: e_1_2_6_8_1
  doi: 10.1186/s12967-014-0260-8
– ident: e_1_2_6_35_1
  doi: 10.1089/scd.2016.0093
– ident: e_1_2_6_7_1
  doi: 10.1126/science.aau6977
– ident: e_1_2_6_46_1
  doi: 10.1242/jcs.170373
– ident: e_1_2_6_97_1
  doi: 10.1038/s41388-017-0116-9
– ident: e_1_2_6_115_1
  doi: 10.3390/jcm7100355
– ident: e_1_2_6_15_1
  doi: 10.1038/ncb2574
– ident: e_1_2_6_109_1
  doi: 10.1016/j.devcel.2016.04.019
– ident: e_1_2_6_17_1
  doi: 10.1194/jlr.R084343
– ident: e_1_2_6_95_1
  doi: 10.1002/adhm.201801268
– ident: e_1_2_6_87_1
  doi: 10.1155/2016/1240301
– ident: e_1_2_6_66_1
  doi: 10.1080/2162402X.2015.1071008
– ident: e_1_2_6_4_1
  doi: 10.1016/j.cub.2018.01.059
– ident: e_1_2_6_23_1
  doi: 10.1038/mtna.2011.2
– ident: e_1_2_6_74_1
  doi: 10.1002/stem.2759
– ident: e_1_2_6_79_1
  doi: 10.1177/0963689718805375
– ident: e_1_2_6_22_1
  doi: 10.1038/ncb1596
– ident: e_1_2_6_76_1
  doi: 10.3727/096368915X687543
– ident: e_1_2_6_47_1
  doi: 10.1371/journal.pone.0084256
– volume: 8
  start-page: 2210
  year: 2018
  ident: e_1_2_6_57_1
  article-title: Exosome mediated multidrug resistance in cancer
  publication-title: Am J Cancer Res
– ident: e_1_2_6_59_1
  doi: 10.1016/j.cell.2014.09.051
– ident: e_1_2_6_99_1
  doi: 10.1038/nature22341
– ident: e_1_2_6_54_1
  doi: 10.1158/0008-5472.CAN-16-1092
– ident: e_1_2_6_94_1
  doi: 10.1002/stem.2448
– ident: e_1_2_6_83_1
  doi: 10.3389/fimmu.2019.01288
– ident: e_1_2_6_81_1
  doi: 10.1186/s12885-015-2025-z
– ident: e_1_2_6_86_1
  doi: 10.1016/j.bbrc.2019.02.005
– ident: e_1_2_6_110_1
  doi: 10.1016/j.ymthe.2018.05.009
– ident: e_1_2_6_33_1
  doi: 10.1007/s11010-019-03526-7
– ident: e_1_2_6_105_1
  doi: 10.1038/mt.2010.105
– ident: e_1_2_6_25_1
  doi: 10.1186/s13287-015-0116-z
– ident: e_1_2_6_52_1
  doi: 10.18632/oncotarget.22371
– ident: e_1_2_6_21_1
  doi: 10.1089/scd.2018.0200
– ident: e_1_2_6_62_1
  doi: 10.1182/blood-2014-03-562439
– ident: e_1_2_6_69_1
  doi: 10.1158/2326-6066.CIR-17-0581
– ident: e_1_2_6_56_1
  doi: 10.1038/s41598-017-13460-7
– ident: e_1_2_6_114_1
  doi: 10.3402/jev.v4.30087
– ident: e_1_2_6_98_1
  doi: 10.1038/mt.2012.180
– ident: e_1_2_6_10_1
  doi: 10.1186/s12943-019-0963-9
– ident: e_1_2_6_24_1
  doi: 10.1038/s41598-018-19581-x
– ident: e_1_2_6_28_1
  doi: 10.1073/pnas.1704862114
– volume: 3
  start-page: e99263
  year: 2018
  ident: e_1_2_6_100_1
  article-title: Generation and testing of clinical‐grade exosomes for pancreatic cancer. JCI
  publication-title: Insight
– ident: e_1_2_6_84_1
  doi: 10.1089/scd.2014.0091
– ident: e_1_2_6_72_1
  doi: 10.1016/j.cell.2019.02.016
– ident: e_1_2_6_73_1
  doi: 10.1038/srep24120
– ident: e_1_2_6_117_1
  doi: 10.1038/nn.3109
– ident: e_1_2_6_101_1
  doi: 10.1016/j.urology.2016.01.028
– ident: e_1_2_6_5_1
  doi: 10.1172/JCI81135
– ident: e_1_2_6_119_1
  doi: 10.1016/S0140-6736(08)60690-X
– ident: e_1_2_6_13_1
  doi: 10.3389/fbioe.2019.00292
– ident: e_1_2_6_29_1
  doi: 10.1080/15384047.2017.1281499
– ident: e_1_2_6_41_1
  doi: 10.1038/s41598-017-02786-x
– ident: e_1_2_6_61_1
  doi: 10.1126/scisignal.2005231
– ident: e_1_2_6_96_1
  doi: 10.1016/j.canlet.2013.02.019
– ident: e_1_2_6_37_1
  doi: 10.1002/stem.1161
– ident: e_1_2_6_55_1
  doi: 10.1007/s11010-013-1746-z
– ident: e_1_2_6_58_1
  doi: 10.2217/epi-2017-0151
– ident: e_1_2_6_104_1
  doi: 10.1038/ncomms2282
– ident: e_1_2_6_2_1
  doi: 10.1002/jor.1100090504
– ident: e_1_2_6_60_1
  doi: 10.3324/haematol.2016.163337
– ident: e_1_2_6_16_1
  doi: 10.1016/j.scr.2015.02.007
SSID ssj0036494
Score 2.6456852
SecondaryResourceType review_article
Snippet Mesenchymal stem cells (MSC) are multipotent stromal cells with the potential to differentiate into several cell types. MSC‐based therapy has emerged as a...
Mesenchymal stem cells (MSC) are multipotent stromal cells with the potential to differentiate into several cell types. MSC-based therapy has emerged as a...
SourceID pubmedcentral
proquest
crossref
wiley
SourceType Open Access Repository
Aggregation Database
Enrichment Source
Index Database
Publisher
StartPage 3100
SubjectTerms Biosynthesis
Cancer
Cell differentiation
Cell signaling
Deoxyribonucleic acid
DNA
Exosomes
Heat shock proteins
Hypoxia
immunomodulation
Inflammation
Kinases
Ligands
Lipids
Membranes
Mesenchymal stem cells
Mitochondrial DNA
MSC‐derived exosomes
Paracrine signalling
Plasma
Review
Ribonucleic acid
RNA
Senescence
Stem cells
Stromal cells
Transfer RNA
SummonAdditionalLinks – databaseName: Wiley Online Library - Core collection (SURFmarket)
  dbid: DR2
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3NTtwwELYQB8SFQgtiKaC04sAlKHHsxBEnhECo0vZQQOKAFHkcW1SUBHV3EXDiEXhGnoQZ56e7qJVQb4k8TmzPTPw5Hn_D2I4xClIVy9AJZ0JhRBbmkEFouXFSJ1mifTqf4ff05Fx8u5AXc2y_OwvT8EP0P9zIM_z3mhxcw2jKySklWIzTPzF9UqwWAaIfPXVUkoq8SWhLb48S3rIKURRPX3N2LvoDMN-GR07DVj_vHH9gl12Lm3CT673JGPbM4xsyx__s0jJbavFocNAY0Aqbs9VHtjBsd9w_sWGTrPIh0FUZTB3WCm7rMQUaYd3aBTd0hslcPdzgLTFDB7Qf8PL0XKJ939kysPf1qEahVXZ-fHR2eBK2KRhCQ1R7IWihaOc0lyB0pGXEQSlpUbvKRLnhDvEmuDiRLpbGIrZAdGM5gAGnXB6XyRqbr-rKrrNAgNIg81yXEAks01qkmhuCpCrjkA_YbqeMwrT85JQm41fRrVNweAo_PAP2tRe9bUg5_ia02Wm0aP1yVHDEX6nHTQP2pS9Gj6Jh0ZWtJyRDyc4RCuMjshlL6F9GnNyzJdXPK8_NnVFGTplhZ7yi_9284vDg1F9svF_0M1vktNz3IW6bbH78e2K3EBONYdsb_ysOzgrO
  priority: 102
  providerName: Wiley-Blackwell
Title Biology and therapeutic potential of mesenchymal stem cell‐derived exosomes
URI https://onlinelibrary.wiley.com/doi/abs/10.1111%2Fcas.14563
https://www.proquest.com/docview/2439600074
https://www.proquest.com/docview/2421460163
https://pubmed.ncbi.nlm.nih.gov/PMC7469857
Volume 111
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3NTtwwEB7xI1W9IH7VLbAKqAcuURPHTpxTBQiEKi1CFKS9RbZji0pssnQXBLc-Qp-xT8KM17uwiPYSJbKTODMT-xt7PB_AF2OkzmUqYsedibnhRVzqQseWGSdUVmTK0_n0zvOza_69L_phwm0UwiqnfaLvqOvW0Bz5V4YjZ-5HvG_Du5hYo2h1NVBoLMIypS4jqy76M4cry3k5IbWlFiQZC5mFKJKHCMVSBA_Z_Hj0AjLfhki-hq5-7DldhZUAGqPDiZbXYME26_ChF5bFN6A3YZR8ilRTR692VEXDdkzRQHhv66IBbTQyN08DvKT0zRFN2v_9_adGI3ywdWQf21GLlTbh-vTk6vgsDjwJsaF8eLFWXNLyZik0V4kSCdNSCosqkCYpDXMICrVLM-FSYSwCAIQglmlttJOuTOtsC5aatrGfIOJaKi3KUtU64VimFM8VM4QbZcF02YGDqbQqE5KIE5fFbTV1JlCwlRdsB_ZnVYeTzBnvVdqZirwKP8-oelF1B_ZmxWj2JBbV2Pae6hAjOeJVfEQxp6rZyyhx9nxJ8_PGJ9AuiDZTFPgxXqn_bl51fPjDn3z-fzu34SMjP9zHnu3A0vjXvd1FsDLWXVhk_KLr7bILy0cn5xeXXe_40_GSPQOhDe8N
linkProvider ProQuest
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3NbtQwEB6VIgEXVP7UhQIGgcQlInHsxDkgVBWqLe32QivtLdiOrSLRZGG3wN54BJ6kD9Un6YyTbLsIuPWWyI5jj8eeGc94PoAX1iqTqURGXngbCSvyqDC5iRy3Xuo0T3WA8xntZ8ND8WEsxytw2t-FobDKfk8MG3XVWDojf81RcmZB4r2dfI0INYq8qz2ERssWu27-A0226Zuddzi_Lznffn-wNYw6VIHIUva4yGihyBlYSCN0rGXMjVLSYYeVjQvLPapQxiep9Im0DsUlCmzHjbHGK18kVYrtXoPrKHhjMvby8cLASzNRtCC6NOI45V0mI4ocIgCzBJWVdFn-XSi1f4ZkXlaVg6zbXoPbnZLKNluuugMrrr4LN0adG_4ejFoEyznTdcUu3eBik2ZG0Uf4bePZMV1sskfzY3yldNGMnARnv35XyPTfXcXcz2baYKX7cHglFHwAq3VTu3VgwihtZFHoysQCy7QWmeaW9FSVc1MM4FVPrdJ2ScsJO-NL2RsvSNgyEHYAzxdVJ22mjr9V2uhJXnaLdVpesNYAni2KcZkRWXTtmhOqQwjoqB9jE_nSVC1-Rom6l0vqz0chYXdOMJ0yx8GESf1398qtzY_h4eH_-_kUbg4PRnvl3s7-7iO4xekMIMS9bcDq7NuJe4yK0sw8CdzJ4NNVL4dzay0mfA
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3NbtQwEB6VrVRxQVBALBRwEUhcoiaOnZ8DqkrbVUvZVQVU6i3Yjq1WosnCboG99RF4Hh6HJ2HGSbZdBNx6S-SJY489nrFnPB_Ac2MynWSRDJxwJhBGpEGuUx1YbpxUcRorD-czHCV7R-LNsTxegp_dXRgKq-zWRL9Ql7WhM_INjpoz8Rpvw7VhEYc7g83x54AQpMjT2sFpNFPkwM6-4fZt8mp_B8f6BeeD3Q_be0GLMBAYyiQXaCUycgzmUgsVKhlynWXSYuMzE-aGOzSntIti6SJpLKpOVN6Wa220y1welTHWewOWU9oV9WD59e7o8F2nB-JE5A2kLvU_jHmb14jiiAjOLELTJV7Uhpcm7p8BmlcNZ6_5BrfhVmuysq1mjt2BJVutwsqwdcrfhWGDZzljqirZlftcbFxPKRYJv60dO6NrTuZkdoavlDyakcvg18WPEkXgqy2Z_V5PaiS6B0fXwsP70Kvqyj4AJnSmtMxzVepQYJlSIlHckNWapVznfXjZcaswbQpzQtL4VHRbGWRs4Rnbh2dz0nGTt-NvRGsdy4tWdCfF5UTrw_q8GIWO2KIqW58TDeGho7WMVaQLQzX_GaXtXiypTk98-u6UQDtlip3xg_rv5hXbW-_9w8P_t_MprKAoFG_3RweP4CanAwEfBLcGvemXc_sYraapftJOTwYfr1sifgMGjiwX
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Biology+and+therapeutic+potential+of+mesenchymal+stem+cell%E2%80%90derived+exosomes&rft.jtitle=Cancer+science&rft.au=Xunian%2C+Zhou&rft.au=Kalluri%2C+Raghu&rft.date=2020-09-01&rft.pub=John+Wiley+and+Sons+Inc&rft.issn=1347-9032&rft.eissn=1349-7006&rft.volume=111&rft.issue=9&rft.spage=3100&rft.epage=3110&rft_id=info:doi/10.1111%2Fcas.14563&rft_id=info%3Apmid%2F32639675&rft.externalDocID=PMC7469857
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1347-9032&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1347-9032&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1347-9032&client=summon